Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3265501000168114 | durvalumab 120 mg / 2.4 mL injection, 2.4 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3265511000168112 | durvalumab 120 mg/2.4 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| durvalumab 120 mg/2.4 mL injection, vial | Is a | durvalumab | true | Inferred relationship | Some | ||
| durvalumab 120 mg/2.4 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| durvalumab 120 mg/2.4 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| durvalumab 120 mg/2.4 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1122160905 | |
| durvalumab 120 mg/2.4 mL injection, vial | has Australian BoSS | durvalumab | true | Inferred relationship | Some | 1122160904 | |
| durvalumab 120 mg/2.4 mL injection, vial | has intended active ingredient | durvalumab | true | Inferred relationship | Some | 1122160904 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial | Is a | True | durvalumab 120 mg/2.4 mL injection, vial | Inferred relationship | Some | |
| durvalumab 120 mg/2.4 mL injection, 2.4 mL vial | has MPUU | True | durvalumab 120 mg/2.4 mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR